This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Mar;55(3):423-5.

doi: 10.1053/j.ajkd.2009.12.014.

Quality of life in CKD patients treated with erythropoiesis-stimulating agents

Patrick S Parfrey, Tyler Wish

PMID: 20189050
DOI: 10.1053/j.ajkd.2009.12.014

Editorial

Quality of life in CKD patients treated with erythropoiesis-stimulating agents

Patrick S Parfrey et al. Am J Kidney Dis. 2010 Mar.

. 2010 Mar;55(3):423-5.

doi: 10.1053/j.ajkd.2009.12.014.

Authors

Patrick S Parfrey, Tyler Wish

PMID: 20189050
DOI: 10.1053/j.ajkd.2009.12.014

No abstract available

PubMed Disclaimer

Comment on

Impact of erythropoiesis-stimulating agents on energy and physical function in nondialysis CKD patients with anemia: a systematic review.
Gandra SR, Finkelstein FO, Bennett AV, Lewis EF, Brazg T, Martin ML. Gandra SR, et al. Am J Kidney Dis. 2010 Mar;55(3):519-34. doi: 10.1053/j.ajkd.2009.09.019. Epub 2009 Dec 23. Am J Kidney Dis. 2010. PMID: 20031287
Systematic review and meta-analysis of exercise tolerance and physical functioning in dialysis patients treated with erythropoiesis-stimulating agents.
Johansen KL, Finkelstein FO, Revicki DA, Gitlin M, Evans C, Mayne TJ. Johansen KL, et al. Am J Kidney Dis. 2010 Mar;55(3):535-48. doi: 10.1053/j.ajkd.2009.12.018. Epub 2010 Feb 4. Am J Kidney Dis. 2010. PMID: 20133033

Similar articles

Triumph and tragedy: anemia management in chronic kidney disease.
Novak JE, Szczech LA. Novak JE, et al. Curr Opin Nephrol Hypertens. 2008 Nov;17(6):580-8. doi: 10.1097/MNH.0b013e32830c488d. Curr Opin Nephrol Hypertens. 2008. PMID: 18941350 Review.
Anemia in renal disease: diagnosis and management.
Lankhorst CE, Wish JB. Lankhorst CE, et al. Blood Rev. 2010 Jan;24(1):39-47. doi: 10.1016/j.blre.2009.09.001. Epub 2009 Oct 14. Blood Rev. 2010. PMID: 19833421 Review.
Is it safe to use erythropoiesis-stimulating agents to treat anemia in chronic kidney disease patients with active malignancies?
Gupta G, Choi MJ. Gupta G, et al. Semin Dial. 2011 Jul-Aug;24(4):379-81. doi: 10.1111/j.1525-139X.2011.00929.x. Epub 2011 Jul 31. Semin Dial. 2011. PMID: 21801225 No abstract available.
Treating anemia with erythropoiesis-stimulating agents: effects on quality of life.
Moossavi S, Freedman BI. Moossavi S, et al. Arch Intern Med. 2009 Jun 22;169(12):1100-1. doi: 10.1001/archinternmed.2009.159. Arch Intern Med. 2009. PMID: 19546408 No abstract available.
Peginesatide: a potential erythropoiesis stimulating agent for the treatment of anemia of chronic renal failure.
Doss S, Schiller B. Doss S, et al. Nephrol Nurs J. 2010 Nov-Dec;37(6):617-26. Nephrol Nurs J. 2010. PMID: 21290916

See all similar articles

Cited by

Comparison of Hemoglobin Levels Before and After Hemodialysis and Their Effects on Erythropoietin Dosing and Cost.
Sagheb MM, Fallahzadeh MA, Moaref A, Fallahzadeh MH, Dormanesh B. Sagheb MM, et al. Nephrourol Mon. 2016 Jun 29;8(4):e38495. doi: 10.5812/numonthly.38495. eCollection 2016 Jul. Nephrourol Mon. 2016. PMID: 27713870 Free PMC article.
Chapter 3: Use of ESAs and other agents to treat anemia in CKD.
[No authors listed] [No authors listed] Kidney Int Suppl (2011). 2012 Aug;2(4):299-310. doi: 10.1038/kisup.2012.35. Kidney Int Suppl (2011). 2012. PMID: 25018950 Free PMC article. No abstract available.
Management of anemia in patients with diabetic kidney disease: A consensus statement.
Bajaj S, Makkar BM, Abichandani VK, Talwalkar PG, Saboo B, Srikanta SS, Das A, Chandrasekaran S, Krishnan PV, Shah A, Abraham G, Tikku P, Kumar S. Bajaj S, et al. Indian J Endocrinol Metab. 2016 Mar-Apr;20(2):268-81. doi: 10.4103/2230-8210.176348. Indian J Endocrinol Metab. 2016. PMID: 27042425 Free PMC article. Review.
A randomised single-blind study to improve health-related quality of life by treating anaemia of chronic kidney disease with Aranesp® (darbepoetin alfa) in older people: STIMULATE.
Roger SD, Jassal SV, Woodward MC, Soroka S, McMahon LP. Roger SD, et al. Int Urol Nephrol. 2014 Feb;46(2):469-75. doi: 10.1007/s11255-013-0512-1. Epub 2013 Aug 28. Int Urol Nephrol. 2014. PMID: 23982766 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information